The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries
Background: Hepatitis C (HCV) can only be eradicated if annual rates of cure (SVR) are consistently and significantly higher than new HCV infections, across many countries. In 2016, the WHO called for a 90% reduction in new HCV infection by 2030. Direct-acting antivirals (DAA) can cure the majority...
Saved in:
Main Authors: | Andrew M. Hill (Author), Sanjay Nath (Author), Bryony Simmons (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
by: Andrew Hill, et al.
Published: (2016) -
Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
by: Melissa J. Barber, et al.
Published: (2020) -
"Sell an Ox" - The Price of Cure for Hepatitis C in Two Countries
by: Ora Paltiel, et al.
Published: (2020) -
O27 Eliminating hepatitis C in the prisons: achievable?
by: Andrew Lloyd
Published: (2017) -
The cost of eliminating hepatitis C in Pakistan
by: Zaigham Abbas, et al.
Published: (2020)